RAMM Pharma

RAMM Pharma Net Debt/Equity

The Net Debt to Equity Ratio of RAMM Pharma (RAMM.CN) as of Nov 3, 2026 is -6.03.

Net Debt/Equity

-6.03

Last updated:

Net Debt to Equity Ratio of RAMM Pharma is 2018 -6.03 . Net Debt to Equity Ratio of RAMM Pharma was 2017 - . It decreases by % lower compared to the previous year.

The RAMM Pharma Net Debt/Equity history

The RAMM Pharma Net Debt/Equity history
YEARNet Debt/EquityYoY
-6.03—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma Corp generates revenue through cannabinoid pharmaceuticals and cannabis-based products, with brands like NettaLife, NettaPet, NettaPet Senior, NettaPet Puppies, and NettaVet targeting pet owners and veterinary markets. The company also sells cosmetics under the Cannabipiel line, including Cannabipiel Nite, Cannabipiel Body Lotion, and Cannabipiel Shampoo, catering to consumers seeking cannabinoid-infused skincare and personal care solutions. Subsidiaries such as Canapar Corp. and Medic Plast SA support production and commercialization across pharmaceutical specialties, household products, and food sectors. The firm’s product portfolio spans pharmaceuticals, pet care, cosmetics, and household items, with NettaPet and NettaVet focusing on animal health and Cannabipiel products targeting human skincare. Revenue streams include direct sales of branded items like Cannabipiel Tite and Cannabipiel Cleaning Emulsion to retail and specialty markets, while subsidiaries handle manufacturing and export operations for global distribution. Brands like Glediser SA and Yurelan SA contribute to the commercialization of diverse product categories under the company’s umbrella. RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

Net Debt to Equity Ratio of RAMM Pharma is -6.03 in 2018.

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's RAMM Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — RAMM Pharma

All Key Metrics — RAMM Pharma